Free Trial
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel
NASDAQ:DRIO

DarioHealth Q3 2026 Earnings Date & Estimates

DarioHealth logo
$5.45 -0.09 (-1.62%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$5.23 -0.22 (-4.04%)
As of 04:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DarioHealth is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from DarioHealth in Q3 2026

DarioHealth is expected to post earnings of -$0.51 per share on revenue of $5.24 million. DarioHealth last reported on August 11, 2026, posting -$0.85 per share and beating the -$1.22 consensus estimate. DarioHealth has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.51
Expected Revenue
$5.24 million

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.85 (Beat by +$0.37)
Last Quarter Revenue
$5.18 million
EPS Beat Rate
5 of last 8 quarters

Prepare for the Q3 2026 Call

DarioHealth Q3 2026 Earnings FAQ

DarioHealth (NASDAQ:DRIO) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

DarioHealth's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect DarioHealth to post earnings of -$0.51 per share for Q3 2026.

The consensus revenue estimate for DarioHealth is $5.24 million for Q3 2026.

DarioHealth Earnings Headlines

Critical Comparison: Veeva Systems (NYSE:VEEV) and DarioHealth (NASDAQ:DRIO)
October 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095360
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
October 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/dariohealth-announces-independent-aon-analysis-that-supports-estimated-2-57-2-in-year-reduction-in-total-healthcare-costs-302897540.html
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
 |  Chaikin Analytics (Ad)
Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives
September 17, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/dario-wins-contract-with-one-of-new-jerseys-largest-health-plans-representing-1-5-million-covered-lives-302881149.html
DarioHealth announces board member retirement, governance remains stable
September 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/dariohealth-announces-board-member-retirement-governance-remains-stable?utm_source=marketbeat.com&utm_medium=referral
DarioHealth Announces Executive Leadership Transition and Consulting Role
August 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/dariohealth-announces-executive-leadership-transition-and-consulting-role?utm_source=marketbeat.com&utm_medium=referral
See More DarioHealth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DarioHealth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DarioHealth and other key companies, straight to your email.

About DarioHealth

DarioHealth (NASDAQ:DRIO) is a digital health company that develops technology designed to help people manage chronic and behavioral health conditions. Its platform combines mobile applications, connected devices, data analytics and personalized coaching to support health-related decision-making and engagement.

The company’s offerings have included tools for diabetes management, hypertension, weight management, musculoskeletal conditions and behavioral health. Products may incorporate connected glucose meters, blood-pressure monitors and other devices that transmit health information to the Dario app, where users can track data, receive insights and access educational or coaching resources.

DarioHealth primarily serves consumers through partnerships with employers, health plans, health-care providers and other organizations. The company was founded in 2011 and has operated internationally, with its platform made available in multiple markets. Its corporate headquarters are in New York, while the company has also maintained operations and development activity in Israel. DarioHealth is led by Chief Executive Officer Rick Anderson.

View DarioHealth Profile
Earnings Tools